Millie
your market intelligence analyst
Search Results
26 results
Your search is now limited to «Lung Cancer» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
PR Newswire 08/21/2019 17:00
MUNICH and BASKING RIDGE, N.J., Aug. 21, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated results and new translational research data from two phase 1 studies evaluating investigational antibody drug conjugates (ADCs) U3-1402...
PR Newswire 08/07/2019 08:31
If a person with mesothelioma or asbestos exposure lung cancer would like to receive the best possible financial compensation it is vital the attorneys-they hire understand asbestos workplace exposure by a plumber or a waterworks worker.
PR Newswire 08/06/2019 08:36
NEW YORK, Aug. 6, 2019 /PRNewswire/ -- The Mesothelioma Victims Center is a national advocate for people with mesothelioma or asbestos exposure lung cancer and their number one priority is seeing to it that people like this receive the very best possible financial compensation results...
PR Newswire 07/31/2019 08:33
NEW YORK , July 31, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We specialize in assisting power plant and every conceivable type of energy worker with mesothelioma or asbestos exposure lung cancer receive the very best possible financial compensation.
PR Newswire 06/27/2019 08:45
WASHINGTON, June 27, 2019 /PRNewswire/ -- The results of the first economic modeling study to estimate the cost-effectiveness of "multi-gene panel sequencing" (MGPS) as compared to standard-of-care, single-gene tests for patients with advanced non-small cell lung cancer (aNSCLC) show that ...
PR Newswire 06/25/2019 09:00
Powered by a unique combination of AI and quality-controlled image analysis services, VIDA's solution aims to provide greater precision and personalization to lung care with its tailored quantitative insights for the treatment and diagnosis of a range of lung diseases, including cancer, emphysema, airway obstructive diseases, asthma and interstitial lung disease.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications